Executive Summary
The September 30, 2026 filings mark a significant escalation in US retail and pharmaceutical distress, with both Petros Pharmaceuticals and Leslie's, Inc. announcing liquidity events that effectively end or restructure their existing equity structures.
Petros Pharmaceuticals executed a General Assignment for the Benefit of Creditors (ABC), a state-law alternative to bankruptcy, resulting in an immediate liquidation event, cessation of operations, and triggering of redemption obligations on preferred stock. Leslie's filed for prearranged Chapter 11 with lender support, aiming to eliminate ~90% of its funded debt ($685M) while securing $150M in new capital and closing 76 stores. Both events are characterized by negative sentiment and maximum materiality, reflecting severe operational and balance sheet stress. The period-over-period data, while not providing specific revenue or margin figures, indicates a complete loss of going concern for Petros and a strategic deleveraging for Leslie's. The market implications are stark: equity holders in both companies face near-total value destruction, while creditors and distressed investors see opportunities in the restructuring. The filings highlight a broader theme of retail and specialty pharmaceutical companies struggling with high leverage and shifting consumer dynamics, leading to insolvency proceedings.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: 8-K
Tracking the trend? Catch up on the prior US Bankruptcy Chapter 11 Insolvency SEC Filings digest from September 21, 2026.
Investment Signals (9)
- Petros Pharmaceuticals ↓ (BEARISH)▲
Executed ABC on Sept 30, 2026, a liquidation event under California law; company ceased all operations and assigned assets to PT Liquidation, LLC, signaling total equity value destruction
- Petros Pharmaceuticals ↓ (BEARISH)▲
ABC triggered immediate redemption obligations on Series A Convertible Preferred Stock, indicating a contractual default event that may accelerate creditor claims
- Petros Pharmaceuticals ↓ (BEARISH)▲
Three directors resigned and two officers terminated/resigned simultaneously, signaling a complete management exodus and governance breakdown
-
Filed prearranged Chapter 11 with support from over 80% of existing lenders, indicating strong creditor coordination and a higher probability of a swift restructuring [BULLISH for distressed debt]
-
Plan eliminates approximately $685M (90%) of funded debt, a massive deleveraging that will significantly improve the balance sheet post-emergence [BULLISH for post-reorg equity]
-
Secured $150M in new capital ($90M DIP + $60M equity), providing ample liquidity to fund operations through the Chapter 11 process [BULLISH for operational continuity]
-
Expects emergence in early 2027 with majority ownership by existing lenders, implying a debt-to-equity conversion that will dilute current shareholders but stabilize the company [NEUTRAL/BEARISH for current equity]
-
Will close 76 stores as part of the restructuring, a rationalization that should improve same-store sales metrics and profitability post-emergence [BULLISH for long-term margins]
-
Gift cards and loyalty benefits will be honored, preserving customer goodwill and brand value, which is critical for a retail recovery [BULLISH for brand equity]
Risk Flags (8)
- Petros Pharmaceuticals/Liquidation↓ [HIGH RISK]▼
ABC is a complete liquidation event; all assets assigned to PT Liquidation, LLC, meaning unsecured creditors may recover only a fraction of claims
- Petros Pharmaceuticals/Going Concern↓ [HIGH RISK]▼
Company explicitly states it can no longer continue as a going concern, eliminating any equity recovery value
- Petros Pharmaceuticals/Contractual Default↓ [HIGH RISK]▼
ABC triggered an event of default under contractual obligations, potentially leading to accelerated claims and litigation
- Petros Pharmaceuticals/Preferred Redemption↓ [MEDIUM RISK]▼
Immediate redemption obligations on Series A Convertible Preferred Stock may create priority disputes among creditors
- Leslie's/Chapter 11↓ [MEDIUM RISK]▼
Filing under Chapter 11, while prearranged, still carries execution risk; any deviation from the RSA could lead to a longer, more costly process
- Leslie's/Store Closures↓ [MEDIUM RISK]▼
Closing 76 stores will result in one-time charges, potential lease rejection costs, and a reduction in revenue base, which may pressure near-term financials
- Leslie's/Equity Dilution↓ [HIGH RISK]▼
Upon emergence, existing lenders will own a majority stake, leading to substantial dilution for current shareholders, who may see their holdings wiped out
- Leslie's/Operational Continuity↓ [MEDIUM RISK]▼
While operations continue, the bankruptcy process can disrupt supply chains and vendor relationships, potentially impacting sales during the holiday season
Opportunities (6)
- Leslie's/Distressed Debt↓ (OPPORTUNITY)◆
With over 80% lender support and a prearranged plan, buying Leslie's secured debt at a discount could yield significant returns upon emergence, as the $150M new capital provides a floor
- Leslie's/Post-Reorg Equity↓ (OPPORTUNITY)◆
If the company emerges in early 2027 with $685M less debt, the reduced leverage could lead to a re-rating of the stock, offering upside for investors who can navigate the bankruptcy process
- Leslie's/Operational Turnaround↓ (OPPORTUNITY)◆
The closure of 76 underperforming stores and the injection of $60M equity financing could drive margin improvement and same-store sales growth post-emergence
- Petros Pharmaceuticals/Asset Play↓ (OPPORTUNITY)◆
The ABC process may lead to a fire-sale of assets; investors with knowledge of the pharmaceutical sector could acquire undervalued intellectual property or product lines from PT Liquidation, LLC
- Petros Pharmaceuticals/Creditor Recovery↓ (OPPORTUNITY)◆
For sophisticated investors, purchasing Petros's unsecured debt at a deep discount could yield recovery value from the liquidation of assets, though recovery rates are uncertain
- Leslie's/Competitive Positioning↓ (OPPORTUNITY)◆
As Leslie's restructures and closes stores, competitors in the pool and spa retail space may gain market share, presenting an opportunity for long-term investors in those competitors
Sector Themes (4)
- Retail Distress Intensifies (SECTOR THEME)◆
Leslie's Chapter 11 filing, following its prearranged restructuring, highlights the ongoing pressure on specialty retailers with high leverage and changing consumer spending patterns, as evidenced by the $685M debt reduction and 76 store closures
- Pharmaceutical Liquidation (SECTOR THEME)◆
Petros Pharmaceuticals' ABC demonstrates that small-cap pharma companies with failed products or cash crunches are increasingly opting for state-law liquidation over Chapter 11, which can be faster but offers less protection from creditors
- Creditor-Led Restructurings (SECTOR THEME)◆
Both filings show a trend toward creditor-controlled outcomes, with Leslie's lenders taking majority ownership and Petros's creditors gaining control through the ABC, indicating a shift in bargaining power from equity to debt holders
- Liquidity Crunch in Small/Mid-Cap (SECTOR THEME)◆
The need for $150M in new capital at Leslie's and the complete asset liquidation at Petros underscore a broader liquidity crisis among companies with high debt maturities and limited access to capital markets
Watch List (6)
- Leslie's/Chapter 11 Proceedings↓ (WATCH)👁
Monitor the progress of the bankruptcy case in the Southern District of Texas, particularly the approval of DIP financing and the restructuring plan; key dates include the hearing on the first-day motions (expected early October 2026)
- Leslie's/Emergence Timeline↓ (WATCH)👁
Watch for updates on the expected emergence in early 2027; any delays could signal complications with the RSA or operational issues
- 👁
Monitor the list of 76 stores to be closed; this will impact local markets and could affect competitors' sales in those regions
- 👁
Track the liquidation of assets by PT Liquidation, LLC, including any sales of intellectual property or product lines; this could provide insight into recovery values for creditors
-
Watch for any legal challenges or disputes regarding the redemption of Series A Convertible Preferred Stock, which could set precedents for other distressed companies
- Sector/Peer Filings (WATCH)👁
Following these events, watch for similar bankruptcy or liquidation filings from other highly leveraged retail or specialty pharma companies, which could indicate a broader trend
Filing Analyses
(2)
30-09-2026
Petros Pharmaceuticals, Inc. (PTPI) filed an 8-K on September 30, 2026, announcing a General Assignment for the Benefit of Creditors (ABC) under California law, assigning all assets to PT Liquidation, LLC for the benefit of creditors. This constitutes a liquidation event, and the company has ceased substantially all business operations, no longer able to continue as a going concern. The ABC triggered immediate redemption obligations for Series A Convertible Preferred Stock and caused the resignation of three directors and the termination/resignation of two officers.
- · The ABC was executed under California law on September 30, 2026.
- · The Assignment constitutes a liquidation event and the company has ceased substantially all business operations.
- · The ABC triggered an event of default under certain contractual obligations and a triggering event under the Certificate of Designations for Series A Convertible Preferred Stock.
- · All outstanding shares of Series A Convertible Preferred Stock are required to be immediately redeemed.
- · Directors Joshua N. Silverman, Bruce T. Bernstein, and Wayne R. Walker resigned effective September 30, 2026.
- · Fady Boctor was terminated as President and Chief Commercial Officer on September 30, 2026.
- · Robert Weinstein resigned as Chief Accounting Officer, Principal Financial Officer, and Principal Accounting Officer effective September 30, 2026, at 5:30 p.m. Eastern time.
- · The resignations and termination were not due to any disagreement with the company.
- · Contact for further information: PT Liquidation, LLC, 2261 Market Street, Suite 95526, San Francisco, CA 94114.
30-09-2026
Leslie's, Inc. filed for prearranged Chapter 11 bankruptcy on September 30, 2026, as part of a Restructuring Support Agreement with over 80% of existing lenders. The plan aims to eliminate approximately $685 million (about 90%) of funded debt, secure $150 million in new capital ($90 million DIP financing and $60 million equity financing), and close 76 stores. Operations will continue in the ordinary course, with gift cards and loyalty benefits honored, and the company expects to emerge in early 2027.
- · Leslie's filed voluntary petitions in the United States Bankruptcy Court for the Southern District of Texas.
- · The company expects to emerge from Chapter 11 in early 2027.
- · Upon emergence, Leslie's expects to be under majority ownership of a group of existing lenders.
- · All gift cards and loyalty program benefits will continue to be honored.
- · Stakeholder information available at https://restructuring.ra.kroll.com/lesliespool and lesliespool.com/our-future/.
- · Kroll contact: (844) 408-3397 (U.S./Canada) or +1 (646) 825-3745 (International).
Get daily alerts with 9 investment signals, 8 risk alerts, 6 opportunities and full AI analysis of all 2 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: US Bankruptcy Chapter 11 Insolvency SEC Filings
September 14, 2026
US Bankruptcy Chapter 11 Insolvency SEC Filings — September 14, 2026
September 08, 2026
US Bankruptcy Chapter 11 Insolvency SEC Filings — September 08, 2026
September 02, 2026
US Bankruptcy Chapter 11 Insolvency SEC Filings — September 02, 2026
August 28, 2026
US Bankruptcy Chapter 11 Insolvency SEC Filings — August 28, 2026
🇺🇸 More from United States
View all →September 23, 2026
US Pre-Market SEC Filings Roundup — September 23, 2026
US Pre-Market SEC Filings Roundup
September 23, 2026
USA Corporate Events Calendar — September 23, 2026
USA Corporate Events Calendar
September 23, 2026
USA Insider Trading Pulse — September 23, 2026
USA Insider Trading Pulse
September 23, 2026
US Executive Officer Management Changes SEC — September 23, 2026
US Executive Officer Management Changes SEC